Cullinan Therapeutics, Inc.

CGEM • NASDAQ • Stock Fundamentals

Cullinan Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Nadim Ahmed, with a market cap of $797.7M.

Market Cap$797.7M

Employees85.0

CEONadim Ahmed

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

View report

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Income Statement Balance Sheet Cash Flow Segments

Financials

Based on Q1 2026 filing

View all metrics

Cullinan Therapeutics, Inc. FAQ

Common questions about Cullinan Therapeutics, Inc.

Cullinan Therapeutics, Inc. (CGEM) has a market capitalization of $797.7M and trades on NASDAQ.

Cullinan Therapeutics, Inc. has approximately 85 employees.

Cullinan Therapeutics, Inc.

Financials

Cullinan Therapeutics, Inc. FAQ

What is Cullinan Therapeutics, Inc.'s market cap?

How many employees does Cullinan Therapeutics, Inc. have?